COVID-19 is an infectious disease caused by the SARSCoV-2 virus, which has given rise to a global sanitary emergency. The clinical characteristics of COVID-19 are varied and can range from an asymptomatic infection to a mild to severe pneumonia. Recent studies have shown that different laboratory parameters become altered in these patients, and as such are useful as biomarkers to assess the progression of the disease and categorize patients that may present a severe and/or fatal clinical condition. This review analyzes biochemical and immunological markers that become altered in COVID-19 patients and their impact on different organs at a hepatic, cardiac, renal and pancreatic level, as well as markers of inflammation, analyzing their implications in the evolution of the disease.

中文翻译：

---

生化标志物在监测 COVID-19 患者中的作用。

COVID-19 是由 SARSCoV-2 病毒引起的传染病，已引发全球卫生紧急情况。COVID-19 的临床特征多种多样，从无症状感染到轻度至重度肺炎。最近的研究表明，这些患者的不同实验室参数发生了改变，因此可用作评估疾病进展并对可能出现严重和/或致命临床状况的患者进行分类的生物标志物。本综述分析了 COVID-19 患者中发生改变的生化和免疫标志物及其对肝脏、心脏、肾脏和胰腺水平不同器官的影响，以及炎症标志物，分析了它们在疾病演变中的影响。